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Abstract
Background: Resident macrophages in the CNS microglia become activated and produce proinflammatory
molecules upon encountering bacteria or viruses. TLRs are a phylogenetically conserved diverse family of sensors
that drive innate immune responses following interactions with PAMPs. TLR3 and TLR4 recognize viral dsRNA Poly
(I:C) and bacterial endotoxin LPS, respectively. Importantly, these receptors differ in their downstream adaptor
molecules. Thus far, only a few studies have investigated the effects of TLR3 and TLR4 in macrophages. However,
a genome-wide search for the effects of these TLRs has not been performed in microglia using RNA-seq. Gene
expression patterns were determined for the BV-2 microglial cell line when stimulated with viral dsRNA Poly (I:C)
or bacterial endotoxin LPS to identify novel transcribed genes, as well as investigate how differences in downstream
signaling could influence gene expression in innate immunity.
Results: Sequencing assessment and quality evaluation revealed that common and unique patterns of proinflammatory
genes were significantly up-regulated in response to TLR3 and TLR4 stimulation. However, the IFN/viral response gene
showed a stronger response to TLR3 stimulation than to TLR4 stimulation. Unexpectedly, TLR3 and TLR4 stimulation did
not activate IFN-ß and IRF3 in BV-2 microglia. Most importantly, we observed that previously unidentified transcription
factors (TFs) (i.e., IRF1, IRF7, and IRF9) and the epigenetic regulators KDM4A and DNMT3L were significantly up-regulated
in both TLR3- and TLR4-stimulated microglia. We also identified 29 previously unidentified genes that are important in
immune regulation. In addition, we confirmed the expressions of key inflammatory genes as well as pro-inflammatory
mediators in the supernatants were significantly induced in TLR3-and TLR4-stimulated primary microglial cells. Moreover,
transcriptional start sites (TSSs) and isoforms, as well as differential promoter usage, revealed a complex
pattern of transcriptional and post-transcriptional gene regulation upon infection with TLR3 and TLR4.
Furthermore, TF motif analysis (-950 to +50 bp of the 5′ upstream promoters) revealed that the DNA
sequences for NF-κB, IRF1, and STAT1 were significantly enriched in TLR3- and TLR4-stimulated microglia.
Conclusions: These unprecedented findings not only permit a comparison of TLR3-and TLR4-stimulated genes
but also identify new genes that have not been previously implicated in innate immunity.
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Background
The immune system includes cells that can recognize
Toll-like receptors (TLRs) and respond to TLR ligands
by expressing several genes that are implicated in innate
immunity, which is the first line of mammalian defense
against invading pathogens. TLRs distinguish conserved
patterns that are derived from microbial pathogens,
which are recognized as pathogen-associated molecular
patterns (PAMPs), including TLR3 (viral double-
stranded RNA (dsRNA)), TLR7/8 (single-stranded RNA
(ssRNA)) and TLR9 (DNA) [1]. The interaction of TLRs
with a PAMP, such as bacterial endotoxin lipopolysac-
charide (LPS) and viral dsRNA, triggers several signaling
cascades that lead to the induction of numerous target
genes involved in inflammation [2]. Polyinosinic-
polycytidylic acid Poly (I:C) is a synthetic analog of viral
dsRNA, which is a PAMP that is generated during the
replication of RNA and DNA viruses and is recognized
by TLR3, while TLR4 is the receptor that recognizes LPS
[2]. TLR3 and TLR4 are unique in that these receptors
can transmit signals through the myeloid differentiation
factor 88 (MyD88)-independent, TIR-domain–contain-
ing adaptor inducing interferon ß (TRIF)-dependent
pathway [3]. Next, MyD88 and TRIF induce the key
transcription factor (TF) nuclear factor κB (NF-κB)
signalosome and mitogen-activated protein kinases
(MAPKs); both pathways facilitate the transcription and
stabilization of mRNAs for proinflammatory mediators,
including cyclooxygenase-2 (COX-2), interleukin-6 (IL-6),
IL-1ß, tumor necrosis factor-α (TNF-α), and IL-12 [4].
Although these signaling molecules and their cascades
have been explored in macrophages, the dynamic out-
come of genome-wide approaches and the effects of TLR3
vs TLR4 in murine microglia remain poorly understood.
Microglia, which are a type of glial cell, are resident
macrophages of the brain and spinal cord that act as
primary effector cells and these cells play an important
role in the brain’s innate immunity, neuronal homeosta-
sis, and neuroinflammatory pathologies [5]. Microglial
cells become rapidly activated in response to infection,
inflammation or injury, and their activation is associated
with the production and secretion of reactive oxygen
species (ROS), nitric oxide (NO) and prostaglandin E2
(PGE2), and a variety of proinflammatory cytokines, in-
cluding IL-1ß, IL-6 and TNF-α [6]. Although microglial
activation is considered a protective mechanism involved
in the clearance of pathogen infection and in the regula-
tion of tissue repair and recovery, excessive or persistent
activation as an uncontrolled immune response stimu-
lates and increases the production of neurotoxic pro-
inflammatory mediators, causing neuroinflammation
and neurological disorders including Alzheimer’s disease
(AD), Parkinson’s disease (PD), brain ischemia and
multiple sclerosis (MS) [6]. Currently, the heterogeneity
of microglia in terms of their activation phenotypes and
their role in neurodegenerative disease progression and
repair is an area of active investigation. Microglia ex-
press all known TLRs to detect and respond robustly to
both Poly (I:C) and LPS [7]. Previous studies have
demonstrated that LPS stimulation induces the gene
expression of IL-1ß, IL-6, TNF-α, inducible nitric
oxide synthase (iNOS) and prostaglandin-endoperoxide
synthase 2 (PTGS-2), as well as the production of NO
and PGE2 in microglial cell cultures [6]. In contrast,
Poly (I:C) activates antiviral and inflammatory genes in-
dependent of the adaptor protein MyD88, which is re-
quired for all other TLRs [3]. However, the full effect on
gene up-regulation and the basis of this synergy is
unknown.
Although a few studies have compared the effects of
Poly (I:C) vs LPS on murine microglia or macrophages
[8, 9], thus far, a genome-wide search for the effects of
Poly (I:C) vs LPS using the RNA-seq specifically has not
been performed in murine microglia. Therefore, we per-
formed gene array studies and comparative gene expres-
sion profiling analyses of BV-2 cells treated with Poly
(I:C) and LPS using RNA-seq. In this study we examined
BV-2 cell lines as a model of inflammation studies. This
is one of the major uses of microglia. Previously, others
reports demonstrated that BV-2 cell lines have close re-
semblance to primary brain microglia [10–12]. Since
BV-2 cells are easy to culture, they are an important tool
to study not only inflammatory processes [12], but also
phagocytosis [13]. Increasing yield and homogeneity of
cells in vitro culture allows for enlarged data output
compared to most in vivo experiments. To the best of
our knowledge, this study is the first to apply these ap-
proaches to assess the differences in response induced
by different TLR ligands and their consequences with re-
spect to global gene expression in BV-2 microglial cells.
Methods
Cell culture and stimulation
Mouse microglial BV-2 cells were grown in high-glucose
Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10 % fetal bovine serum (FBS) (catalog #
26140), 100 IU/ml penicillin, and 10 μg/ml streptomycin
(catalog # 15140; Invitrogen, USA). The cells were main-
tained in a humidified incubator with 95 % air and a 5 %
CO2 atmosphere at 37 °C. The cells were incubated with
LPS (10 ng/ml, Sigma-Aldrich) and Poly (I:C) (5 μg/ml,
Sigma-Aldrich) for the specified times under normal
culture conditions. The medium, which contained the
appropriate agents, was replaced every other day. The
NF-κB pathway Inhibitor BAY11-7082 was purchased
from Calbiochem (San Diego, CA, USA). Unless other-
wise indicated, BAY11-7082 was freshly dissolved before
use in the experiments. In this study, we used 10 μM of
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BAY11-7082 [14–16]. Primary microglial cells were iso-
lated from 3-day-old ICR mice as previously described
[17, 18]. All experimental protocols were conducted in
accordance with Institutional Animal Care and Use
Committee (IACUC) guidelines and were approved
by the IACUC committee at Hanyang University (HY-
IACUC-2014-0164A). Briefly, whole brains of neonatal
mice were taken; blood vessel and meninges were care-
fully removed. Then, the whole brains of 12 mice were
pooled together, finely minced, and digested with Neural
Tissue Dissociation Kit-Postnatal Neurons (Miltenyi
Biotec-130-094-802). Next, digested cells pass through
70-μm nylon cell strainer (BD Biosciene) and were
seeded in poly-L-lysine-coated T-75 flask in DMEM/
nutrient mixture F-12 (DMEM/F12, 1:1) containing
20 % FBS (catalog # 26140), 100 IU/ml penicillin and
10 μg/ml streptomycin (catalog # 15140) from Invitro-
gen (CA, USA). The cells were maintained in a humidi-
fied incubator with a 95 % air/5 % CO2 atmosphere at
37 °C. The medium was changed every 2–3 days. After
two weeks in culture, mixed glial cell cultures are shaken
at 150 rpm at 37 °C for 45 min, and the glial cell suspen-
sion was collected from each flask and seeded on
poly-L-lysine coated cell culture plate. Microglial cells
were sub-plated and used for further experiments.
Total RNA extraction
Total RNA (~8 μg) was extracted using TRIzol (Life
Technologies, Carlsbad, CA, USA) according to the
manufacturer’s instructions. Briefly, 200 μl of chloroform
was added, and the tubes with the lysis mixture were
gently inverted for 5 min. The mixture was centrifuged
at 12,000 x g for 15 min at 4 °C, and the clear upper
solution was placed into a new tube, to which 500 μl of
isopropanol was added. The tubes were inverted before
incubation on ice for 1 h. The lysis mixture was centri-
fuged at 12,000 x g for 10 min at 4 °C, and the isopropa-
nol was decanted. Ice-cold 70 % ethanol was added to
the RNA pellet for gentle washing. The ethanol was
removed after centrifugation as indicated above for
10 min. The RNA pellets were dried at room
temperature for 5–10 min before reconstitution in 20 μl
of RNase-free water, and the RNA was treated with
RNase-free DNase I (Promega, WI, USA). The RNA
quality was assessed using an Agilent 2100 Bioanalyzer
with an RNA 6000 Nano Chip (Agilent Technologies,
Waldbronn, Germany), and the quantity was determined
using a spectrophotometer (NanoDrop Technologies,
Wilmington, DE, USA).
Quantitative real-time RT-PCR (qRT-PCR)
The reverse transcription of the RNA samples was per-
formed as previously described [19] using 2 μg of total
RNA, 1 μl of random hexamers (per reaction) and a
Prime Script 1st strand cDNA Synthesis Kit (Takara,
Japan). The random hexamers and RNA templates were
mixed and denatured at 65 °C for 5 min, followed by
cooling for 2 min on ice. Prime Script buffer (5x), RTase
and RNAse inhibitor were added to the cooled template
mixture and incubated for 1 h at 50 °C before enzyme
inactivation at 70 °C for 15 min. qRT-PCR was performed
using SYBR Green PCR Master Mix (Takara Bio Inc.,
Shiga, Japan) and a 7500 Fast Real-time PCR System
(Applied Biosystems, Foster City, USA). Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) was used as an in-
ternal control. Complementary DNA samples were diluted
1.5-fold, and qRT-PCT was performed using an AB-7500
Real-time PCR System (Applied Biosystems, Foster City,
CA, USA) with SYBR Premix Ex-Taq II (Takara Bio, Shiga,
Japan) according to the manufacturer’s instructions. The
reactions were performed in a total volume of 20 μl that
contained 0.4 mM of each primer (Table 1). Each PCR
run included a no-template control that included water
instead of cDNA and a reverse transcriptase-negative con-
trol for each gene. Triplicate measurements were per-
formed for all reactions. Different samples were evaluated
using 96-well plates for gene expression experiments, and
all samples were analyzed on a single plate for endogenous
control determination. The results were analyzed using
the critical threshold (ΔCT) and comparative critical
threshold (ΔΔCT) methods in the AB-7500 software pro-
gram with the Norm finder and geNorm-plus algorithms.
The primers were designed using Primer Express software
(Applied Biosystems, Foster City, CA, USA).
cDNA library preparation for RNA-seq
Total RNA was extracted from each group of BV-2 cells
i.e., control 2 h (2 samples), control 4 h (2 samples), LPS
2 h (2 samples), LPS 4 h (2 samples), Poly (I:C) 2 h (2
samples) and Poly (I:C) 4 h (2 samples), using TRIzol®
(Life Technologies) according to the manufacturer’s in-
structions. For RNA-Seq, RNA libraries were created
from each group of BV-2 cells using a NEBNext® Ultra™
Directional RNA Library Preparation Kit from Illumina®.
The first step in the workflow involved the removal of
ribosomal RNA using an RNAMius™ Transcriptome
Isolation Kit (Life Technologies). Following purification,
total RNA was fragmented into small pieces using diva-
lent cations at elevated temperatures. The cleaved RNA
fragments were subjected to first-strand cDNA synthesis
using reverse transcriptase and random primers,
followed by second-strand cDNA synthesis using DNA
polymerase I and RNase H. The cDNA fragments were
subsequently processed using an end-repair reaction
after the addition of a single ‘A’ base, followed by adapter
ligation. The products of these reactions were purified
and enriched through PCR to generate the final cDNA
library. The cDNA fragments were sequenced using an
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Illumina HiSeq2500 System (101 cycles, paired-end (PE)
lane) (National Instrumentation Center for Environmen-
tal Management in Seoul National University). Biological
duplicate RNA sequencing was performed on twelve
independent RNA samples from the treated BV-2 cells.
Differential gene expression analysis
Raw sequence files were subjected to quality control
analysis using FastQC software (http://www.bioinforma-
tics.babraham.ac.uk/projects/fastqc/). To ensure high-
quality data, we clipped the adapters and trimmed the
reads using the FASTX-Toolkit (http://hannonlab.csh-
l.edu/fastx_toolkit/). The quality-checked reads for each
condition were processed using the TopHat version
2.0.10 software package (Bowtie 2 version 2.2.1 software)
as FASTQ files to analyze differentially expressed genes
[20]. The reads were mapped to the reference genome
[Mus musculus UCSC mm10 sequence], and the align-
ment files were generated as BAM files. These files were
used as the input for Cufflinks software, which is a com-
plementary method used to generate assembled tran-
scripts for each condition; the abundance was evaluated
using read data. The “fragments per kilobase per million
map reads” (FPKM) values were calculated for each gene
to normalize the data [21]. These assemblies are used
with the Cuffquant and Cuffdiff tools from the Cufflinks
2.2.1 package to calculate the differential expression
levels and to evaluate the statistical significance of the
detected alterations [22]. RNA-seq experiments were
normalized and visualized using HOMER software
(http://homer.salk.edu/homer/) after preparing custom
tracks for the UCSC Genome browser (http://geno-
me.ucsc.edu/).
Functional annotation
DAVID (Database for Annotation, Visualization and In-
tegrated Discovery) version 6.7 software (http://davi-
d.abcc.ncifcrf.gov/home.jsp) was used to determine the
most functional annotation of significant genes in the
datasets as previously described [23]. The DAVID pro-
gram calculates a modified Fisher’s exact P value to
demonstrate gene ontology (GO) or molecular pathway
enrichment. P values less than 0.05 were considered
strongly enriched in the annotation category.
Canonical pathway analysis of datasets
Ingenuity Pathway Analysis (IPA) (Ingenuity Systems,
http://www.ingenuity.com, Mountain View, CA, USA)
was conducted to analyze the most significant canonical
pathways in datasets as previously described [19, 24].
The genes from datasets associated with canonical path-
ways in the Ingenuity Pathways Knowledge Base
Table 1 List of primers used in qRT-PCR studies
Gene designation Forward sequence (5′ - >3′) Reverse sequence (5′ - >3′)
TNF-α CAG GCG GTG CCT ATG TCT C CGA TCA CCC CGA AGT TCA GTA G






CXCl10 TGC TGG GTC TGA GTG GGA CT CCC TAT GGC CCT CAT TCT CAC
IRF-1 ATG CCA ATC ACT CGA ATG CG TTG TAT CGG CCT GTG TGA ATG
IRF-7 GCGTACCCTGGAAGCATTTC GCACAGCGGAAGTTGGTCT
JUNB CTATCGGGGTCTCAAGGGTC CTGTTGGGGACGATCAAGC




KDM4A GAC CAC ACT CTG CCC ACA C TCC TGG GGT ATT TCC AGA CA
IFN-b AGCTCCAAGAAAGGACGAACA GCCCTGTAGGTGAGGTTGAT
IRF3 GAG AGC CGA ACG AGG TTC AG CTT CCA GGT TGA CAC GTC CG
KLF7 AGT GGA CAT TTT GCT CTC TCG GTT AAT GAG GTC ACT GCG TTG A
IRAK3 GTTCTACTCCTGTTCCGTCACC GTCCCGTTGCTCATATAGGGATA
GAPDH TGCGACTTCAACAGCAACTC CTTGCTCAGTGTCCTTGCTG
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(IPAKB) were considered for literary analysis. The sig-
nificance of the associations between datasets and ca-
nonical pathways was measured in the following
manner: (1) the ratio of the number of genes from the
dataset that mapped to a canonical pathway divided by
the total number of genes that mapped to the same ca-
nonical pathway; and (2) Fisher’s exact test for a P value
indicating the probability that the association could be
explained by chance. After uploading the datasets, gene
identifiers were mapped to corresponding gene objects,
and the genes were overlaid onto a global molecular net-
work in the IPAKB. Gene networks were algorithmically
generated based on connectivity.
Graphical representation of networks and pathways
The molecules from the normalized filtered RNA-seq
dataset were each mapped to corresponding objects in
the IPAKB for network generation. A fold change cutoff
of up-regulated genes (≥1.5 log2-fold) was set to identify
significantly and differentially regulated genes in BV-2
microglial cells at 2 and 4 h after Poly (I:C) and LPS
stimulation. The graphical representation of molecular
relationships between genes and gene products is based
on genes or gene products, which are represented as
nodes, and the biological relationship between two
nodes is represented as an edge (line). All edges were
supported by at least one reference from the literature,
textbook or canonical information in the IPAKB. The
node color intensity indicates the degree of up-
regulation (red). The nodes are displayed using shapes
to represent functional classes of gene products.
Transcription factor binding motif enrichment analysis
NCBI reference sequence mRNA accession numbers
were subjected to transcription factor binding motif ana-
lysis using the web-based software Pscan (http://
159.149.109.9/pscan/) [25]. The JASPAR database of
transcription binding factor sequences was analyzed
using enriched groups of -950 base pair (bp) sequences
to +50 bp of the 5′ upstream promoters [26]. The range
of -950 to +50 was selected from the range options in Pscan
software to obtain the best coverage for a -1000 to +50 bp
range.
Enzyme-linked immunosorbent assay (ELISA)
Primary microglial cells were cultured in the same con-
dition as above. Primary microglial cells were treated
with Poly (I:C) (5 μg/ml) and (LPS 10 ng/mL), for 2 h
and 4 h. After treatment, the concentration of the pro-
inflammatory mediators DNMT3L, TNF-α, IL-1ß and
CCL4 were determined in cell culture supernatants
using the mouse ELISA kit according to the manufac-
turer’s protocol. The mouse ELISA kit DNMT3L from
Elabscience (Wuhan, China) and TNF-α, IL-1ß and
CCL4 from Komabiotec (Seoul, Korea).
Statistical analysis
The data were analyzed using Origin Pro 8 software
(Origin Lab Corporation, Northampton, MA, USA).
Each value is expressed as the mean ± standard error of
the mean (SEM). The statistical analysis was performed
using SPSS 17.0 software (SPSS Inc., IL, USA). The data
were tested using a one-way ANOVA, followed by
Tukey’s HSD post-hoc test. *P <0.05 and **P <0.001 were
considered significant.
Results
RNA-Seq transcriptional profiles of murine microglia in
response to TLR3 vs TLR4
To establish a high-resolution transcriptome in response
to TLR stimulation, we treated BV-2 microglial cells
with Poly (I:C) or LPS for 2 and 4 h before cDNA library
preparation for RNA-seq experiments. The RNA-seq
transcriptional analysis was performed using two inde-
pendent samples (biological replicates) of each treat-
ment. The data from all experiments (each group) were
combined, and the genes whose levels of expression sig-
nificantly differed were identified. We used a 1 % false
discovery rate (FDR), P <0.001, and fold change ≥1.5 log2
for up- or down-regulation as the criteria for defining
differentially expressed genes. Of note, using qRT-PCR,
we found that most of the inflammatory response-
related genes were up-regulated at the 2 and 4 h time
points (data not shown). We chose these time points for
transcriptional profiling; these time points were also
used in other studies [27, 28] that investigated the gen-
eral induction pattern of microglial activation by Poly
(I:C) or LPS. Details outline of the experiments is
depicted in Fig. 1.
The RNA-seq analysis revealed many genes are up-
regulated in response to either Poly (I:C) or LPS stimula-
tion, with many genes in common between the two TLR
ligands. Importantly, we found that Poly (I:C) and LPS
elicit the induction of a unique gene set in response to
stimulation with this TLR ligand at both time points
(Additional file 1). The genes were grouped into several
categories based on their biological processes and mo-
lecular gene ontology functions, and heat maps were
generated to aid the visualization of the gene expression
pattern. The top 150 up-regulated inflammatory genes
(P <0.001) at 2 and 4 h after Poly (I:C) and LPS stimula-
tion in BV-2 microglia cells is depicted in Fig. 2a. Be-
cause the down-regulated genes were not associated
with inflammation (data not shown), only the up-
regulated genes were further studied. Next, we performed
functional classification analyses of the up-regulated genes
(P <0.001, and fold change ≥1.5 log2) using DAVID
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Informatics Resources through classification into GO
categories (FDR 0.05) based on biological process
(BP) and molecular function (MF) categories and on
KEGG (Kyoto Encyclopedia of Genes and Genomes)
pathways. The unique genes up-regulated in response
to LPS stimulation were involved in stimulus re-
sponses and cellular processes, whereas the genes up-
regulated in response to Poly (I:C) stimulation were
involved in cellular processes. In contrast, both LPS-
and Poly (I:C)-activated genes were involved in im-
mune system processes, biological regulation and
stimulus responses (Fig. 2b and c).
Gene network analysis and canonical pathways
modulated through TLR3- and TLR4-stimulated BV-2
microglial cells
The differentially expressed genes (DEGs) (P <0.001, and
fold change ≥1.5 log2) were examined by IPA (IPA, In-
genuity Systems, http://www.ingenuity.com) to identify
the canonical pathways by mapping these transcripts to
the IPA program and to gain further insight into the mo-
lecular functions of these genes. Two metrics were used to
recognize the most significant downstream effects of these
overexpressed genes: the activation z-score and P value. A
positive z-score implies increased functional activity. The
Fig. 1 Schematic outline of experiments and data analysis
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P value, which is calculated using Fisher’s exact test, indi-
cates the likelihood that the relationship between a set of
genes in our dataset and a biological function is consider-
able. The top 5 canonical pathways for the differentially
expressed genes at the two time points are displayed in
Fig. 3c and d and Additional file 2 C and D. Almost all
functions predicted to be activated in response to TLR3
and TLR4 stimulation (positive z-score) were related to
the immune system; pattern recognition receptors play
roles in bacteria and virus recognition NF-κB signaling,
and TLR signaling. The up-regulation of these functions
in response to TLR3 and TLR4 stimulation is interesting
and supports the strength of our approach but is rather
predictable. Next, we utilized IPA to explore the set of in-
put genes to generate networks using the IPKB for inter-
actions between identified DEGs. The IPA analysis
revealed the top two networks of the differentially
expressed genes established at either the 2 or 4 h time
Fig. 2 Differential gene expression and downstream effect analysis of genes overexpressed in microglia upon TLR3 and TLR4 stimulation at two
different time points. a Heat map representing RNA-seq gene expression of top 150 up-regulated inflammatory genes at 2 and 4 h after Poly (I:C)
and LPS stimulation in BV-2 microglia cells compared with controls. P <0.001, fold change≥1.5 log2 for the significant determination of DEGs.
Each row shows the relative expression level for a single gene, and each column shows the expression level of a single sample. Yellow represents
genes with increased expression, and green represents genes with decreased expression. b and c Gene Ontology analysis of functional annotations
(biological process) associated with Poly (I:C) and LPS-inducible up-regulated genes in BV-2 microglia in comparison with the control
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point after TLR3 and TLR4 stimulation in BV-2 cells.
Networks 1 and 2 are illustrated in Fig. 3a and b and
Additional file 2 A and B. Interestingly, the top networks
involved in infectious diseases and inflammatory response
were characterized by the activation of interferon regula-
tory factor 1 (IRF1), NF-κB2 and signal transducer and ac-
tivator of transcription 2 (STAT2). The activation of IRF1,
NF-κB2 and STAT2 has been reported in several models
regarding inflammatory response [29, 30]. Of note, al-
though IRF1 signals are essential for infectious diseases
and for the inflammatory response of TLR4, IRF1, NF-κB2
and STAT2 were predicted to exhibit higher activation
under TLR3 stimulation (Fig. 3a and b). The four net-
works depicted in Fig. 3a and b and Additional file 2 A
and B show that several genes that are crucial to infectious
diseases and inflammatory responses are expressed at
higher levels in TLR3- and TLR4-stimulated BV-2 cells.
Notably, this high expression was the case for Il-1ß,
ISG15, and CASP4, which are crucial for infectious
diseases [31–33].
Differential induction of proinflammatory cytokines,
chemokines and interferon response genes by TLR3 and
TLR4 stimulation
The effects of Poly (I:C) and LPS treatments on cyto-
kine, chemokine and interferon response gene expres-
sion were examined in BV-2 microglial cells to simplify
the RNA-seq data analysis for the identification of TLR3
and TLR4-stimulated genes. Poly (I:C) induces pathways
similar to those induced by LPS, leading to the production
Fig. 3 Top IPA-based network involved in infectious diseases and canonical pathway analyses at 4 h after TLR3 and TLR4 stimulation. a, b Ingenuity®
Bioinformatics pathway analysis of gene networks displaying interactions between infectious disease-related genes that were differentially expressed
at 4 h after Poly (I:C) and LPS stimulation. Genes in white circles were not in our DEG dataset but were inserted by IPA because these genes are
connected to this network. The activity of molecules highly connected to this network, namely, NF-κB2, STAT2, and IRF1 (hubs), was assessed using the
IPA molecule activity predictor. c, d The most highly represented canonical pathways for differentially expressed genes in BV-2 microglial cells after Poly
(I:C) and LPS stimulation
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of proinflammatory cytokines such as IL-6, TNF-α and
IFN-regulated genes (IRGs), as well as the chemokine
CXCL10 in mouse cells [9]. As expected, our RNA-Seq
analysis revealed that proinflammatory cytokines (IL-1ß
and IL1A) were highly induced by Poly (I:C) and LPS
stimulation in microglia, with Poly (I:C) being more po-
tent than LPS. The reverse situation was true for TNF-α
(Fig. 4a and b). Interestingly, unlike other proinflamma-
tory cytokines, IL-6 was not induced in microglia. How-
ever, Poly (I:C) was described by another group to induce
IL-6 mRNA in human dendritic cells (DCs) [34]. The
chemokine displaying the highest level of up-regulation
was the IRF3-dependent gene CXCL10. Interestingly,
CXCL10-associated CXCR3-binding chemokines (CXCL9)
and I-TAC (CXCL11) were not induced in Poly (I:C)-
and LPS-stimulated BV-2 microglial cells. The GRO
oncogenes (CXCL1 and CXCL3) observed a similar
trend. Rantes (CCL5) and monocyte chemoattractant
proteins (MCP) 1 and 3 (CCL2 and CCL7, respect-
ively) were also up-regulated, with no clearly discern-
ible pattern of induction by the two TLR ligands.
CCR7, which is a DC antigen that is expressed in
microglia in inflamed CNS tissues [35], stromal-
derived factor 1 (SDF-1: CXCL12) and the recently
discovered chemokine CCL25 were not induced.
Next, we assessed the expression levels of several
IRG genes with either the TLR3 agonist Poly (I:C) or
the TLR4 agonist LPS. These IRGs included those
involved in antiviral responses. These IRGs were
among the most vastly induced genes in both the
Poly (I:C) and LPS arrays. These highly induced
genes included MX2, OAS2, OAS3, IFN-induced pro-
tein with tetratricopeptide (IFIT) family genes IFIT1
(p56) and IFIT2 (p54), IRF3-dependent genes ISG15
[32], IFI35, IFI203, and IFI204, with Poly (I:C) being
more potent than LPS (Fig. 4a). Interestingly, we
could not detect other IRGs including MX1, ISG20,
IFN-induced transmembrane proteins IFITM1 and
IFITM3, GBP1 and GBP2 [36] in Poly (I:C)- and LPS
stimulated BV-2 microglial cells in this study. These
data strongly suggest that both Poly (I:C) and LPS
selectively induce proinflammatory cytokines, chemo-
kines and interferon response genes in BV-2 micro-
glial cells.
Fig. 4 Inflammatory gene expression patterns in TLR3- and TLR4-stimulated BV-2 microglia cells. a Heat map representation depicting the expression
of positive regulators of inflammatory genes (P <0.001; fold change≥1.5 log2) at 2 and 4 h after Poly (I:C) and LPS stimulation compared with controls.
b UCSC browser images representing normalized RNA-seq read densities after Poly (I:C) (left panel) and LPS (right panel) stimulation in BV-2 microglia
cells compared with controls at the indicated times
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Fig. 5 (See legend on next page.)
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Different TFs in multiple families of RNA-Seq data are
activated by TLR3 and TLR4 stimulation in BV-2 microglial
cells
Among the DEGs, multiple families of TFs were identi-
fied at 2 and 4 h after Poly (I:C) and LPS stimulation in
BV-2 microglial cells (Fig. 5a and b). Poly (I:C) and LPS
stimulation elicited a pronounced transcriptional re-
sponse in BV-2 microglial cells at both time points.
These TFs, including IRF, Kruppel-like factor (KLF), NF-
κB and STAT, play important roles in neuroinflamma-
tory diseases [29, 30]. The RNA-seq analysis revealed
that STAT1 and IRF1 were highly induced by Poly (I:C)
and LPS in microglia, with Poly (I:C) being more potent
than LPS. The reverse situation was true for NF-κBIA
and KLF7. Interestingly, another group found that Poly
(I:C) was unable to activate NF-κB in DCs and macro-
phages (MØs) [37]. In contrast, our RNA-seq analysis
revealed that NF-κB TFs were highly up-regulated in
BV-2 microglial cells after Poly (I:C) stimulation. How-
ever, IRF2, IRF4, IRF6, IRF8, STAT6, KLF1, KLF2, KLF4,
and KLF5 were unaffected after Poly (I:C) and LPS
stimulation, suggesting that Poly (I:C)- and LPS-induced
gene expression is highly selective in BV-2 microglial
cells. In addition, the RNA-seq reads also revealed that
JUNB, JUND, POU2F2, and ETS2 were particularly up-
regulated by Poly (I:C) and LPS in microglia, with Poly
(I:C) being more potent than LPS. The reverse situation
was true for ATF3 and SFPI1 (PU.1) (Fig. 5a). Next, we
conducted a TF motif analysis to assess Poly (I:C)- and
LPS-induced gene expression in BV-2 microglial cells.
We used the Pscan software tool [25] to perform the in
silico computational analysis of over-represented cis-
regulatory elements within the 5′-promoter regions of
coordinately regulated genes. Applying this score to the
promoters of the genes differentially expressed at 2 or
4 h (≥ 1.5 log2-fold) in response to Poly (I:C) and LPS
stimulation revealed that the DNA sequences for NF-
kB1, IRF1, and STAT1 were significantly enriched
(Fig. 5c). In addition to TF motif analysis, we also used
IPA software to identify the target genes that were dir-
ectly or indirectly activated by identified TFs in response
to TLR3 and TLR4 stimulation. Importantly, we found
that the expression of the majority of cytokines and
chemokines was directly regulated by the identified TFs,
including IRF1, IRF7, STAT1, JUNB, CREPD, and NF-
κBIA, whereas JUNB and CREPD target genes were
unique in response to TLR3 and TLR4 stimulation, re-
spectively (Fig. 5d and e and Tables 2 and 3). To further
functionally classify the NF-κBIA and STAT1-regulated
genes, it was functionally annotated using DAVID 6.7
software package. Interestingly, we observed strong en-
richments of GO terms for the NF-κBIA and STAT1-
regulated transcripts associated with the immune system
processes, multicellular organism processes, locomotion
and response to stimulus in Poly (I:C) and LPS response
BV-2 microglial cells (Fig. 5f and g). To probe again
whether NF-κB pathway inhibitor Bay 11-7082 [14–16]
triggered deregulation of inflammatory genes, we mea-
sured the expressions of selected inflammatory genes
upon exposure to Bay 11-7082 and we found that Bay
11-7082 significantly down-regulates the expression of
NF-κB target genes in Poly (I:C) and LPS induced BV-2
microglial cells (Fig. 5h and i ). Taken together, these
data strongly indicate that multiple families of transcrip-
tion factors might be involved in the regulation of BV-2
microglial cell activation in response to TLR3 and TLR4
stimulation.
Comparison of the transcriptional and post-
transcriptional regulation by TLR3 and TLR4 stimulation
in BV-2 microglial cells
Transcriptionally regulated differentially expressed isoforms
have different transcriptional start sites (TSSs), while post-
transcriptionally regulated differentially expressed isoforms
have the same TSSs [21]. The transcripts, isoforms and
TSSs of the genes that were up-regulated (≥ 1.5 log2-fold)
in Poly (I:C)- and LPS-stimulated BV-2 cells after 2 and 4 h
were investigated in the present study. We defined the fol-
lowing three groups of genes (Fig. 6a and b): genes
with one TSS and one isoform, which were classified
as “un-spliced and transcriptionally regulated”; genes
with one TSS and more than one isoform, which were
classified as “spliced and post-transcriptionally regu-
lated”; and genes with more than one TSS and more
than one isoform, which were classified as “spliced
and both transcriptionally and post-transcriptionally
(See figure on previous page.)
Fig. 5 Transcriptomic analysis of selected TF families in BV-2 microglial cells. a Heat map represents differential expression of NF-κB, STAT, KLF,
and IRF TF families, as well as other TF genes, (P <0.001) at 2 and 4 h after Poly (I:C) and LPS stimulation in BV-2 microglial cells. b UCSC browser
images representing normalized RNA-seq read densities for TF expression after Poly (I:C) (left panel) and LPS (right panel) stimulation in BV-2
microglia cells compared with controls. c Patterns of transcription factor motif enrichments within the promoters of the genes in Poly (I:C)- and
LPS-stimulated BV-2 microglia cells. d, e The activity of highly connected positive regulators of the inflammatory genes IRF1, IRF7, JUNB, NF-κBIA,
STAT1, and CREPD led to the activation of this network, as assessed using the IPA molecule activity predictor in Poly (I:C)- and LPS-stimulated
BV-2 microglia cells. f, g Results of the GO term analysis using DAVID on genes that were regulated by NF-κBIA and STAT1 in Poly (I:C) and LPS
response BV-2 microglial cells respectively. (H, I) The IL1A, CCL7 and CCL2 genes were significantly down-regulated in NF-κB inhibitor Bay 11-7082
(10 μM)-treated BV-2 microglial cells at 2 h and 4 h under inflammatory conditions (Poly (I:C) 5 μg/ml and LPS 10 ng/mL). Gene expression was
normalized to GAPDH transcript levels. *P <0.05 and **P <0.001 compared with the control. The data represent three independent experiments
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regulated”. Our RNA-seq analysis revealed that the
highest percentages of genes that were both Poly
(I:C)- and LPS-regulated were un-spliced and tran-
scriptionally regulated. Importantly, this analysis also
indicated that Poly (I:C) was more potent for spliced
and both transcriptionally and post-transcriptionally
regulated genes than LPS. The reverse situation was
true for spliced and post-transcriptionally regulated
genes (Fig. 6a and b).
Different epigenetic regulators in multiple families of
RNA-Seq data are activated by TLR3 and TLR4 stimulation
in BV-2 microglial cells
We also identified the most significant epigenetic regula-
tors in multiple families that were altered in TLR ligand-
stimulated BV-2 microglial cells; epigenetic regulation is
defined as genetic control through factors other than the
DNA sequence [38]. Studies of epigenetic regulation to
potentiate innate immune responses have recently
emerged [39]. Our RNA-seq analysis provides the first
evidence that of multiple families of epigenetic regula-
tors, only DNA methyltransferase (DNMT3L), histone
methyltransferase (SETDB2), and histone demethylases
(KDM4A) were particularly up-regulated by Poly (I:C)
and LPS stimulation in microglia, with LPS being more
potent than Poly (I:C). The reverse situation was true for
histone methyltransferase SETDB2 (Fig. 7a and b), sug-
gesting that DNMT3L, KDM4A, and SETDB2 might be
involved in the regulation of BV-2 microglial cell
activation.
Identification of novel genes synergistically up-regulated
by TLR3 and TLR4 stimulation in BV-2 microglial cells
Many studies have investigated the effects of TLR li-
gands, particularly TLR4, on cytokines, chemokines, and
interferon response genes, as well as of different TF fam-
ilies on macrophages, which are important in inflamma-
tory diseases. However, none of these studies has
focused on novel genes that are also potentially involved
in inflammatory diseases. To gain greater insight into
mRNA expression studies, our RNA-seq analysis unex-
pectedly revealed approximately 29 previously unidenti-
fied genes that were particularly up-regulated by TLR
ligands. Surprisingly, these 29 novel genes are frequently
overexpressed not only in Poly (I:C)-induced microglial
responses but also in LPS-induced microglial responses
(Fig. 7c and d). Notably, the up-regulated genes that ex-
hibited the significant links with inflammation included
CLEC4E, RSAD2, PDE4B, GPR84, IER3, SLC15A3,
CASP4, FCGR4, PELI1, PIK2, RNF114 and TREX, which
are known to play important roles in inflammatory dis-
orders [33, 40–42]. We observed that the RSAD2,
Table 2 Leads to activation of inflammatory genes by identified TFs in response to TLR3 stimulation
STAT1 predicted to be
activated (45 genes)
p = 4.76 e-43)
IRF7 predicted to be
activated (45 genes)
(p = 1.33 e-43)
NFKBIA predicted to
be activated (35 genes)
(p = 5.31 e-30)
IRF1 predicted to be
activated (24 genes)
(p = 7.19 e-22)
JUNB predicted to
be activated (7 genes)
(p = 1.24 e-07)
USP18, TRAFD1, TNF, TAP1,
STAT2, SP110, SOCS3, SLFN5,
SLFN2, SLFN13, SLFN12L,
RSAD2, PTGS2, OASL, NEURL3,
MX1/MX2, JAK2, ISG15, IRGM1,
IRG1, IRF9, IRF7, IRF1, IL15,
IGTP, IFIT2, IFIT1B, IFI35, IFI16,
ICAM1, HERC6, EIF2AK2,
CXCL10, CMPK2, CDKN1A,
CD40, CD274, CD14, CCRL2,




TAP1, STAT2, STAT1, SAMD9L,
RTP4, RSAD2, PLSCR1, PHF11,
PELI1, PARP14, PARP12,
OASL2, OASL, OAS3, OAS2,
OAS1, MX1/MX2, JAK2, ISG15,
IRGM1, IRGM, IRF9, IRF1, IL15,
IGTP, IFIT2, IFIT1B, IFIH1, IFI35,




SLFN2, SAA3, RCAN1, RASA3,
PTGS2, PLAU, NFKBIE, NFKB2,
JUNB, JUN, ISG15, IRG1, IRF1,
IL1RN, IL1A, IL15, IFIT1B, IFI16,
ICAM1, HMOX1, HLA-A,
GCH1, CLU, CEBPD, CCL9,
CCL7, CCL3L3, CCL2, CASP4,
AMPD3, MXD4, CXCR4
TRIM21, TNF, TLR3, TAP1,
STAT2, STAT1, RSAD2, PTGS2,
PML, OAS1, JAK2, ISG15, IRF9,
IRF7, IL1B, IL18, IL15, IFIT2,





Table 3 Leads to activation of inflammatory genes by identified TFs in response to TLR4 stimulation
IRF7 predicted to be
activated (43 genes)
(p = 3.25 e-38)
STAT1 predicted to
be activated (36 genes)
(p = 3.02 e-32)
NFKBIA predicted to
be activated (35 genes)
(p = 5.88 e-25)
IRF1 predicted to
be activated (20 genes)
(p = 1.10 e-14)
CEBPD predicted to be activated
(11 genes) (p = 1.22 e-10)
USP18, XAF1, UBA7, TRIM5,
TRIM30A, TRIM21, TREX1,
TAP2, TAP1, STAT2, STAT1,
SAP30, RSAD2, PHF11,
PELI1, PARP14, PARP12,
OASL2, OASL, OAS3. OAS2,
OAS1, MX1/MX2, ISG15,
IRGM1, IRGM, IRF9, IRF1,
IRF7, IGTP, IFIT2, IFIT1B,
IFIH1, IFI16, HELZ2, DHX58,
DAXX, CXCL10, CMPK2,
CCRL2, CASP4, ADAR, TLR8





ISG15, IRGM1, IRG1, IRF9,










JUNB, ISG15, IRG1, IRF1,
IL1RN, IL1A, IFIT1B, IFI16,
ICAM1, HMOX1, HLA-A,
GCH1, CP, CFLAR, CEBPD,
CEBPB, CCL9, CCL7, CCL2,
CCL3L3, CASP4, BTG2,
AMPD3, CXCR4
TRIM21, TNF, TLR3, TAP1,
TAP2, STAT2, STAT1,
RSAD2, PTGS2, OAS1,
ISG15, IRF9, IRF7, IL1B,
IL18, IFIT2, IFIH1, EIF2AK2,
CXCL10, CDKN1A,
TNF, SAA3, PTGS2, PAX3, IKBKE,
HP, CEBPB, CD14, CCL3,
CCL2, C3
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FCGR4, and RNF114 genes displayed higher up-
regulation upon Poly (I:C) stimulation than upon LPS
stimulation. The reverse situation was true for PDE4B,
IER3, SLC15A3, PIK2 and TREX.
Confirmation of differentially expressed genes through
qRT-PCR
Many differentially regulated genes identified in the
RNA-Seq analysis were subjected to validation through
real-time qRT-PCR using GAPDH as a reference gene.
The TLR3- and TLR4-affected genes were primarily se-
lected for validation. To measure gene expression,
mRNA was reverse transcribed into cDNA using Prime
Script™ Reverse Transcriptase (Takara Bio Inc., Shiga,
Japan); the qRT-PCR assays were repeated several times
using at least 3 mRNA preparations from independent
experiments. The results are expressed as fold changes
relative to the control levels. Eighteen genes were se-
lected for verification; the RNA-seq expression patterns
were confirmed for sixteen genes (IL-1ß, IL1A, TNF-α,
PTGS2, CCL3, CCL4, CCL7, CXCL10, IRF1, IRF7,
JUNB, NF-κBIA, CLEC4E, GPR84, SLC15A3 and
KDM4A; Fig. 8a and b and Tables 4 and 5), and the ex-
pression levels of two genes (KLF7 and IRAK3) were
non-significant in the qRT-PCR analysis compared with
the RNA-seq experiments (Tables 4 and 5). To confirm
whether those genes were induced in primary microglial
cells, we incubated primary microglial cells under in-
flammatory conditions Poly (I:C) (5 μg/ml) and (LPS
10 ng/mL), which induced inflammatory genes including
IL-1ß, IL1A, TNF-α, PTGS2, CCL3, CCL4, CCL7,
CXCL10, IRF1, IRF7, JUNB, NF-κBIA, CLEC4E, GPR84,
SLC15A3 and KDM4A (Fig. 9a and b). Importantly, it
should be noted that in primary microglial cells most of
the inflammatory genes were induced stronger than BV-
2 cell lines. In addition, we analyzed cytokines/chemo-
kines in the supernatants of treated primary microglial
cells with ELISAs. Compared to untreated cells
DNMT3L, TNF-α, IL-1ß and CCL4 in the supernatants
were increased in primary microglial cells following 2 h
and 4 h Poly (I:C) (5 μg/ml) and (LPS 10 ng/mL) treat-
ment (Fig. 9c and d).
Discussion
Microglial cells become rapidly activated through inter-
actions with pathogens, and their persistent activation is
associated with the production and secretion of various
pro-inflammatory genes, cytokines and chemokines,
which may initiate or amplify neurodegenerative diseases
[5]. Previous studies have reported that LPS stimulation
Fig. 6 Transcriptional and post-transcriptional regulatory effects on overall transcript output in BV-2 microglia cells. a, b Pie charts showing the
three categories of transcriptional and post-transcriptional regulation of genes at 2 h (upper panel) and 4 h (lower panel) after Poly (I:C) and LPS
stimulation in BV-2 microglia cells
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induces the gene expression of TNF-α, IL-1β, IL-6, iNOS
and PTGS-2 and the production of NO and PGE2 in
primary and BV-2 microglial cell cultures [6]. In con-
trast, Poly (I:C) activates antiviral and inflammatory
genes independent of the adaptor protein MyD88, which
is required for all other TLRs [3]. However, none of
these studies addressed the effects of TLR ligands Poly
(I:C) and LPS; thus, their responses were compared
using RNA-seq analysis in microglial cells in the present
study. This study provides the most comprehensive ana-
lysis thus far because, compared to microarrays, this
technique can provide unbiased profiles, can be ex-
tremely accurate, and can identify novel transcribed
regions if a sufficient level of coverage is obtained
[43, 44]. Furthermore, these technologies facilitate the
determination of the difference between the expres-
sion of alternative mature mRNAs from the same
precursor and the identification of the differential
expression of mRNA isoforms [43–45]. Validation
techniques such as qRT-PCR [46] have corroborated
the accuracy of RNA-seq.
The RNA-seq analysis revealed that cytokines/chemo-
kines, antiviral genes, and IRGs associated with inflam-
mation were significantly up-regulated in response to
TLR3- and TLR4-induced microglial activation. Both the
extent of the fold change and the number of genes were
Fig. 7 RNA-seq analysis reveals that TLR3 and TLR4 induce epigenetic regulators and novel inflammatory related genes. a, c Heat map representation
depicting the expression of epigenetic regulators families and novel inflammatory related genes (P <0.001; fold change≥1.5 log2) at 2 and 4 h after
Poly (I:C) and LPS stimulation compared with controls. b, d UCSC browser images representing normalized RNA-seq read densities of epigenetic
regulators and novel inflammatory related genes after Poly (I:C) and LPS stimulation in BV-2 microglia cells compared with controls at the
indicated times
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significantly modulated. The activation of TNF-α, IL-1β,
IL-1A, PTGS-2, CXCL10 (IP-10), CCL7, CCL12, CCL4,
and CCL2, all occurred similarly, with minor variations
(Fig. 4a and b). IL-1 is the most widely studied pro-
inflammatory gene; the extensively characterized forms
of IL-1 are IL-1A and IL-1β. IL-1A and IL-1β play a cru-
cial role in the development of AD and PD, the patho-
genic hallmark of which is CNS inflammation. Following
Fig. 8 Confirmation of differentially expressed genes by quantitative reverse transcription-polymerase chain reaction. a, b IL-1ß, IL1A, TNF-α,
PTGS2, CCL3, CCL4, CCL7, CXCL10, IRF1, IRF7, JUNB, NF-κBIA, CLEC4E, GPR84, SLC15A3 and KDM4A genes were significantly up-regulated in Poly
(I:C)- and LPS-stimulated BV-2 microglia cells. Gene expression was normalized to the GAPDH transcript levels. *P <0.05 and **P <0.001 compared
with control. The data represent three independent experiments
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Table 4 Comparison of fold change values from RNA-seq data and qRT-PCR in 2 h LPS and Poly I:C treated BV-2 microglia cells
RNA-seq fold change qRT-PCR fold change
Gene symbol Gene accession ID LPS_2h Poly I:C_2h LPS_2h Poly I:C_2h
Il-1ß NM_008361 93.82 96.13 89.02 96.72
Il1A NM_010554 57.04 82.69 67.98 99.02
TNF NM_001278601 51.12 45.94 55.94 69.01
PTGS2 NM_011198 32.41 51.93 36.5 35.09
CXCL10 NM_021274 34.74 88.57 12.53 87.45
CCL4 NM_013652 50.02 60.01 65.23 42.25
CCL7 NM_013654 17.41 44.98 52.23 35.26
CCL3 NM_011337 37.15 22.61 39.66 22.23
NFκBIA NM_010907 38.57 33.60 42.36 30.21
IRF7 NM_001252600 21.59 34.28 19.68 26.35
JUNB NM_008416 20.3 22.01 22.25 22.02
IRF1 NM_001159393 14.31 26.35 16.79 18.23
CLEC4E NM_019948 53.91 53.29 47.52 45.25
GPR84 NM_030720 44.69 47.16 51.25 41.23
SLC15A3 NM_023044 18.0 16.23 22.03 11.23
KDM4A NM_001161823 23.29 18.41 19.55 16.23
KLF7 NM_033563 4.89 3.85 1.04 0.909
IRAK3 NM_028679 4.97 4.25 0.77 0.89
Table 5 Comparison of fold change values from RNA-seq data and qRT-PCR in 4 h LPS and Poly (I:C) treated BV-2 microglia cells
RNA-seq fold change qRT-PCR fold change
Gene symbol Gene accession ID LPS_4h Poly I:C_4h LPS_4h Poly I:C_4h
Il1ß NM_008361 98.06 91.24 107.99 84.02
Il1A NM_010554 66.01 82.29 77.23 96.32
TNF NM_001278601 57.25 46.18 21.33 50.02
PTGS2 NM_011198 61.7 45.1 42.56 31.02
CXCL10 NM_021274 88.25 79.58 19.64 105.1
CCL4 NM_013652 69.71 61.29 74.25 67.52
CCL7 NM_013654 39.89 68.01 61.66 51.02
CCL3 NM_011337 45.34 30.07 47.85 30.21
NFκBIA NM_010907 31.46 24.92 39.98 27.45
IRF7 NM_001252600 51.23 54.66 42.25 30.21
JUNB NM_008416 18.46 16.16 17.58 17.23
IRF1 NM_001159393 17.02 31.08 17.61 26.53
CLEC4E NM_019948 57.85 57.51 62.03 51.89
GPR84 NM_030720 45.93 45.79 57.89 43.58
SLC15A3 NM_023044 30.12 27.72 27.89 19.86
KDM4A NM_001161823 17.16 11.20 22.00 12.23
KLF7 NM_033563 4.22 3.24 1.05 0.896
IRAK3 NM_028679 6.99 7.13 1.22 1.102
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CNS damage, IL-1 is rapidly released from activated
microglia, and an elevated level of the IL-1 cytokine is
an important hallmark of neuroinflammation [26].
PTGS-2 is the key enzyme responsible for brain inflam-
mation, and increased PTGS-2 expression contributes to
neurodegeneration [47]. Chemokines are key regulators
of inflammation, and the excessive production of these
molecules has been associated with disease progression
and severe inflammation pathologies, including MS.
Conductier et. al.(2010), reported that CCL2 plays a
crucial role in neuroinflammatory diseases and is consid-
ered a target in the treatment of neuroinflammatory dis-
orders [48]. CCL2 and CCL7 are highly expressed in
microglia, astrocytes and other inflammatory cells dur-
ing MS [49]. CCL12 also plays an inflammatory role
because the levels of this chemokine are up-regulated in
both microglia and astrocytes when stimulated with the
proinflammatory cytokine IL-17 [50]. The expression of
CXCL10 is observed during infectious and inflammatory
diseases, playing a crucial role in T-cell-mediated inflam-
mation in the CNS. In addition, CXCL10 plays a role in
inflammatory demyelinating diseases, such as MS,
through the destruction of the myelin sheath or neu-
rons by facilitating leukocyte trafficking in the brain
[51]. These patterns are consistent with our studies
showing the consequences of TLR3 and TLR4 stimu-
lation with respect to the induction of cytokines/
chemokines (Fig. 4a and b).
Various signaling pathways, including phosphoinosi-
tide 3-kinase, Jun N-terminal kinase (JNK), p38, NF-κB,
Fig. 9 Confirmation of differentially expressed genes and release of pro-inflammatory mediators in primary microglial cells. a and b IL-1ß, IL1A,
TNF-α, PTGS2, CCL3, CCL4, CCL7, CXCL10, IRF1, IRF7, JUNB, NF-κBIA, CLEC4E, GPR84, SLC15A3 and KDM4A genes were significantly up-regulated in
Poly (I:C)- and LPS treated primary microglia cells. Gene expression was normalized to the GAPDH transcript levels. c and d Primary microglial cell
culture supernatants of Poly (I:C)- and LPS treated cells were subjected to ELISA to detect the levels of pro-inflammatory cytokines/chemokines.
Therefore, primary microglial cells were treated with Poly (I:C)- and LPS for 2 h and 4 h, followed by quantification of DNMT3L, TNF-α, IL-1ß and CCL4
levels. Values are given in pg/ml. Means and standard deviations of the mean of three independent experiments are shown (*P <0.05, **P <0.001,
compared with control). The data represent three independent experiments
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extracellular signal-related kinase, and IRF3, have been
activated by TLR3/TLR4, leading to the induction of
numerous target genes involved in antiviral immunity,
including IFN-ß and IP-10 production [9]. Our RNA-seq
data revealed that the induction of several genes in-
volved in antiviral immunity and signaling was more po-
tent in TLR3-stimulated BV-2 microglial cells than in
TLR4-stimulated BV-2 microglial cells and included
IFIT1, ISG15, IFIT2, IFI203, IFI204, IRF1, IRF7, IRF9,
STAT1, and STAT2 (Fig. 4a). These results were rather
anticipated because TLR3 is unique, recruiting only
TRIF and not MyD88. Unexpectedly, we were unable to
identify IRF3 and its target gene IFN-ß, but not IP-10, in
TLR3/TLR4-stimulated BV-2 microglial cells. Our data
show consequences similar to that in a previously pub-
lished report regarding the induction of IRF3 in DCs
and MØs [37]. However, because no IRF3 activation
could be observed in BV-2 microglia cells, the mechan-
ism by which the production of IP-10 and IRGs is
regulated in these cell types remains unclear. This mech-
anism is the subject of ongoing investigations. Further-
more, to evaluate the expressions of IRF3, IFN-ß, and
IP-10 (CXCL10) on TLR3- and TLR4-induced primary
microglial cells we measured the expressions of IRF3,
IFN-ß, and IP-10 for 2 h and 4 h time points. Interestingly,
we found that IFN-ß, and IP-10 were significantly up-
regulated in primary microglial cells (Additional file 3 A
and B and Fig. 9a and b). Although, primary microglial
cells with these factors did not induce the expression of
IRF-3 (Additional file 3 A and B). Nevertheless further
studies are warranted to assess genome wide transcrip-
tomic analysis on TLR3-and TLR4-stimulated primary
microglial cells. Importantly, we first identified IRF1, IRF7,
and IRF9 as significantly up-regulated in response to
TLR3- and TLR4-stimulated microglia (Fig. 5a). A previ-
ous study reported that IRF7 could be a master regulator
of type-I IFN-mediated responses [52]. In addition, IRF1
has been suggested to be a master transcription factor
contributing to IRGs [53]. Thus, exploring whether inter-
feron response gene induction mechanisms not relying on
IRF3 may exist in cells other than microglia or macro-
phages would be interesting. Therefore, IRF7, IRF1, and
IRF9 most likely do not act in place of IRF3 in BV-2
microglia cells in response to TLR3 and TLR4 stimulation.
This possibility is an exciting area that we are keenly pur-
suing further.
In addition to IRF TFs, we identified NF-κB and STAT,
as well as additional TFs (PU.1, KLF7, JUNB, ATF3, and
FOXP4) whose roles in microglia activation have not yet
been well established (Fig. 5a and b). We observed the
significant up-regulation of NF-κB transcription factor,
which was induced by Poly (I:C) and LPS stimulation in
microglia, with LPS being more potent than Poly (I:C).
Similar to our findings, Reimer et. al. (2008) reported
that Poly (I:C) and LPS induce the activation of NF-κB,
followed by the release of TNF-α [9]. JUNB also plays an
important role in controlling activity-dependent gene
programs that are critical for nervous system function
[54]. However, IRF2, IRF4, IRF6, IRF8, STAT6, KLF1,
KLF2, KLF4, and KLF5 were unaffected by Poly (I:C)
and LPS stimulation, suggesting the highly selective in-
duction of TFs through TLR3 and TLR4 stimulation in
BV-2 microglial cells. To delineate conserved transcrip-
tion factor-binding motifs further, we performed TF
motif analysis on TLR3- and TLR4-stimulated genes in
BV-2 microglial cells. The core promoters of co-
expressed genes (typically, regulatory regions within
-1000 to +50 bp relative to the TSS) can be evaluated for
overrepresented cis-regulatory elements after partition-
ing into suitable modules [55]. Of the two ranges avail-
able in Pscan software that are closest to this region of
interest (-950 to 50 and -1000 to 0), the -950 to +50 bp
range was selected for the analyses. The promoters of
differentially expressed genes revealed the enrichment of
DNA sequences not only for NF-κB transcription factors
but also for IRF1 and STAT1, as shown in Fig. 5c. These
analyses converged the first insights into 3 TF binding
motifs that may be involved in regulating subset-specific
genes in Poly (I:C)- and LPS-stimulated BV-2 microglial
cells. Next, we used IPA software to identify the target
genes that were directly or indirectly activated by the
identified TFs in response to TLR3 and TLR4 stimulation.
Importantly, we found that the majority of the cytokines,
chemokines whose expression is directly regulated by the
identified TFs, including IRF1, IRF7, STAT1, JUNB,
CREPD, and NF-κBIA, where JUNB and CREPD target
genes were unique in response to TLR3 and TLR4, re-
spectively (Fig. 5d and e and Tables 2 and 3).
We performed the first functional analysis of the tran-
scripts, isoforms and TSSs to gain greater insight into
the functional categories for Poly (I:C) and LPS-
stimulated inflammatory genes in BV-2 microglial cells.
Most of the differentially expressed genes in microglial
following Poly (I:C) and LPS stimulation were expressed
as several isoforms subjected to transcriptional/post-
transcriptional regulation and/or to differential promoter
usage. We classified these genes into three primary
groups (genes with one isoform and one TSS; genes with
more than one isoform and one TSS; and genes with
more than one isoform and more than one TSS) (Fig. 6a
and b). The first two groups included genes crucial for
the innate immune response, which might be under
stronger selection to prevent the emergence of new iso-
forms and/or post-transcriptional regulation. In addition,
some genes belonged to the third group [56], suggesting
that these genes could be subjected to positive selection
by transcriptional and post-transcriptional regulation in
Poly (I:C)- and LPS-stimulated BV-2 microglial cells.
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Interestingly, we found that spliced and both transcrip-
tional and post-transcriptional regulated genes were
greater in Poly (I:C)-stimulated BV-2 microglia than in
LPS-stimulated BV-2 microglia after unspliced and tran-
scriptionally regulated genes. The reverse situation was
true for LPS-stimulated genes. However, further targeted
studies are required to validate this regulation and to es-
tablish the potential effects of these genes during TLR3
and TLR4 stimulation in microglia.
Another interesting finding is the increased expression
of epigenetic regulators, which involves chemical modifi-
cations of DNA cytosine residues and DNA-bound his-
tone proteins without alterations in the DNA sequence;
epigenetic regulation is promising as one of the major
factors regulating gene expression in response to envir-
onmental stimuli [38]. Recent studies have demonstrated
that histone demethylase (KDM6B) and histone deacety-
lases (HDAC1, HDAC2, HDAC3, and HDAC7) poten-
tially regulate proinflammatory gene expression in
macrophages [39, 57, 58]. Recently, we showed that the
histone demethylase KDM4A was significantly expressed
in neuroectodermal stem cells and might play a role in
tumorigenic development [19]. Interestingly, among dif-
ferent epigenetic regulators, only histone demethylase
KDM4A and DNA methyltransferase DNMT3L were
strikingly differentially expressed in Poly (I:C)- and LPS-
stimulated BV-2 microglial cells, with LPS being more
potent than Poly (I:C), as determined by the RNA-Seq
data in the present study (Fig. 7a and b). The mechan-
ism by which KDM4A and DNMT3L become activated
following TLR3 or TLR4 receptor stimulation remains
unknown; determining how these epigenetic regulators,
along with modified TFs, can regulate distinct set of in-
flammatory genes in microglial cells would be intriguing.
We posit that the role of these genes in inflammatory
diseases should now be assessed in animal models
involving TLR-specific gene deletion or overexpression.
However, histone demethylase (KDM6B) and histone
deacetylases (HDAC1, HDAC2, HDAC3, and HDAC7),
were not expressed in either Poly (I:C)- or LPS-
stimulated BV-2 microglial cells.
One of the most striking features is that our RNA-seq
analysis was the first to identify several notable differ-
ences in the pattern of previously unidentified genes ac-
tivation induced by these distinct TLR ligands in BV-2
microglial cells. In particular, this technology allowed us
to identify over 25 direct TLR3- or TLR4-stimulated
genes in these cells. The direct TLR3- or TLR4-stimulated
genes known to be important for activity-regulated pro-
cesses in microglia include the macrophage-inducible C-
type lectin (CLEC4E), which regulates immune responses
to pathogens [40]; the secreted endo-lysosomal peptide
transporter SLC15A3, which is highly expressed by bone
marrow-derived dendritic cells after LPS stimulation and
which plays a key role in regulating innate immune re-
sponses [42]; orphan G protein-coupled receptor 84
(GPR84), which is highly expressed in leukocytes, mono-
cytes, and macrophages upon activation by LPS and which
plays a critical role in immunological regulation [41]; and
caspase-4, which plays an important role in inflammatory
diseases [33]; (Fig. 7c and d). This finding indicates that
these TLR3 or TLR4 targets also mediate the effects of the
inflammatory response in mouse microglia. Furthermore,
we confirmed the expression of key inflammation- and
immunity-related genes as well as cytokines/chemokines
in the supernatants were significantly induced in Poly
(I:C) and LPS treated primary microglial cells including
IL-1ß, IL1A, TNF-α, PTGS2, CCL3, CCL4, CCL7,
CXCL10, IRF1, IRF7, JUNB, NF-κBIA, CLEC4E, GPR84,
SLC15A3 and KDM4A (Fig. 9a, b, c and d). Future studies
determining how these TLR3 or TLR4 target genes are
expressed during the immune response in mouse micro-
glia will be useful. This mechanism is the subject of
ongoing investigations.
Overall, our RNA-seq data provide novel insights into
the transcriptional landscape TLR3 and TLR4 ligands
mimic certain aspects of viral infection by triggering key
molecular events such as a rapid innate immune response
during the early course of the inflammatory response.
Regardless of certain boundaries in exactitude, TLR3- and
TLR4-stimulated inflammatory gene expression profiles, TF
and epigenetic regulator clusters, and microglial cis-regula-
tory elements predictions offer valuable information for fu-
ture studies, such as potential gene targets for chromatin
immunoprecipitation (ChIP)-seq assays. In the future, this
model can be extended to include data from other high-
dimensional surveys, such as microRNA, ChIP-seq, and
proteomics, providing further insight into global gene
regulation in TLR3- and TLR4-stimulated microglial cells.
Conclusion
In summary, using RNA-seq, our study is the first to
identify family-wide DEGs of most known and un-
known immune genes that characterize the microglial
response to two TLR stimuli, Poly (I:C) and LPS and
to demonstrate both common and unique patterns. In
addition, our data argue that, while both TLR3 and
TLR4 have been evolutionarily selected to induce
antiviral gene expression, TLR3 seems to be even
more specialized than TLR4 to initiate antiviral re-
sponses and that the reverse situation was true for
the master TF NF-κB. Furthermore, we examined
epigenetic regulators, different TFs, and TF-regulated
genes, as well as the transcriptional and post-
transcriptional regulation of genes based on their
isoforms, TSSs and differential promoters in two TLR-
stimulated BV-2 microglial cells. These unprecedented re-
sults together indicate that both known and unknown
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DEGs, TFs, and epigenetic regulators identified in the
present study may provide new insight regarding the
innate immunity to TLR3 and TLR4 in BV-2 micro-
glial cells and may enhance our knowledge of
neuroinflammation.
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